GE Health leverages AI and data integration technologies to help address the rapidly increasing volume of patient data and strives to optimize the application of these two technological tools in patient care in announcing 40 new innovations at RSNA23.
The company’s core strategy is to integrate AI into its precision care framework, encompassing smart devices, targeted therapies, disease-specific solutions and digital solutions, including its Theranostics Journey Manager, which aims to provide providers with a tool to coordinate oncology care and identify patients who may be potential candidates for theranostics.
Another offering announced at RSNA23 by the medtech giant is SIGNA Champion, its 1.5T scanner using AI to streamline workflows to support efficiency with high-quality images.
GE HealthCare has accumulated 58 FDA 510(k) clearances or clearances for AI-based medical devices in the United States.
The company also offers CardioVisio, an atrial fibrillation (AFib) patient management dashboard designed to improve clinical confidence and save time.
GE HealthCare said collaborations with Nuance and Microsoft resulted in a research project exploring the automation of assembling relevant pre-studies for radiologists. This automation, in turn, can help optimize imaging workflows.
“Our vision encompasses a centralized view of patients, uniting data within and beyond hospitals, providing real-time insights for informed treatment decisions,” said Dr. Taha Kass-Hout, Chief Technology Officer at GE HealthCare, in a press release. “With GE HealthCare, clinicians work smarter, not harder, driving substantial change. »
THE BIGGEST TREND
Philips announced the launch of its BlueSeal MR Mobile at RSNA23, a transportable MRI system that can be placed in a truck. The scanner connects to the Philips Radiology Operations Command Center, bringing together remote imaging experts and technologists via real-time peer-to-peer video, audio or text chat.
GE HealthCare is a major player in theranostics, which uses digitalization technologies to combine therapeutics and diagnostics to advance oncology care.
Last month, the company announced a in partnership with Michigan-based BAMF Health Cancer Center to strengthen theranostics adoption by creating a framework to support scalable solutions that help advance precision medicine in the United States
In addition to expanding theranostics into oncology care, GE HealthCare has worked to help providers use data.
The amount of health data collected has grown exponentially over the past decade, and the data deluge is forcing stakeholders in the health data ecosystem to rethink the design and increase their capabilities to unlock the full value health data.
According to a recent Deloitte study, 30% of the world’s data comes from the healthcare sector, but 97% of data generated by hospitals remains untapped. investigation.
A initiative of the Sequoia project focuses on the adoption of the Data Usability Implementation Guide, which focuses on the interoperability of reliable and usable data in healthcare.
